CAS NO: | 2349371-81-7 |
包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
生物活性 | GNE-616 is a highly potent, metabolically stable, orally bioavailable, and subtype selectiveNav1.7inhibitor (Kiof 0.79 nM andKdof 0.38 nM for hNav1.7) for the treatment of chronic pain. GNE-616 shows >1000 nM Kdand >2500-fold selectivity over hNav1.1, hNav1.3, hNav1.4, and hNav1.5. Selectivity over hNav1.2 and hNav1.6 is more modest at 31- and 73-fold, respectively[1]. | ||
IC50& Target[1] |
| ||
体外研究 (In Vitro) | Site-directed mutagenesis is critical for the isoform selectivity profile of GNE-616 (hNav1.7, Kd: Y1537s/W1538=170±67 nM, V1541=3.9±1.1 nM, Y1537s/W1538/V1541=790±350 nM)[1]. | ||
体内研究 (In Vivo) | GNE-616 shows robust activity in a Nav1.7-dependent inherited erythromelalgia (IEM) PK/PD model with an EC50of 740 nM and EC50,u of 9.6 nM[1]. | ||
分子量 | 537.53 | ||
Formula | C24H23F4N5O3S | ||
CAS 号 | 2349371-81-7 | ||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |